Bayer (BAYN) Stock Forecast & Price Target

Compare

769 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BAYN Analyst Ratings

Moderate Buy

4 Buy

9 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Bayer

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BAYN Stock 12 Month Forecast

Average Price Target

€28.08

▼(-1.20% Downside)

Based on 13 Wall Street analysts offering 12 month price targets for Bayer in the last 3 months. The average price target is €28.08 with a high forecast of €35.00 and a low forecast of €23.00. The average price target represents a -1.20% change from the last price of €28.42.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"18":"€18","27":"€27","36":"€36","22.5":"€22.5","31.5":"€31.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€35.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28.08,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€28.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€23.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[18,22.5,27,31.5,36],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.12,28.64923076923077,29.17846153846154,29.70769230769231,30.236923076923077,30.76615384615385,31.295384615384616,31.824615384615385,32.353846153846156,32.88307692307692,33.41230769230769,33.941538461538464,34.47076923076923,{"y":35,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.12,28.11692307692308,28.113846153846154,28.110769230769233,28.107692307692307,28.104615384615386,28.10153846153846,28.09846153846154,28.095384615384614,28.092307692307692,28.089230769230767,28.086153846153845,28.08307692307692,{"y":28.08,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.12,27.726153846153846,27.332307692307694,26.93846153846154,26.544615384615387,26.15076923076923,25.756923076923076,25.363076923076925,24.96923076923077,24.575384615384614,24.181538461538462,23.787692307692307,23.393846153846155,{"y":23,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.139,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.895,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.299,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.979,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.193,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.221,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.536,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":22.601,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.208,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.03,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.14,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.46,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€35.00

Average Price Target€28.08

Lowest Price Target€23.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Veda Pharmyne

TR | OpenAI - 4o

€28→€29

Hold

2.04%

Upside

Reiterated

08/20/25

AI Generated ArticleAI Generated Article

Chris Counihan

Jefferies

€25

Hold

-12.03%

Downside

Reiterated

08/18/25

Jefferies Sticks to Their Hold Rating for Bayer (0P6S)

Matthew Weston

UBS

€24→€26

Hold

-8.52%

Downside

Reiterated

08/14/25

Sebastian Bray

Berenberg Bank

€26

Hold

-8.52%

Downside

Reiterated

08/12/25

Bayer (0P6S) Receives a Hold from Berenberg Bank

Peter Spengler

DZ BANK AG

―

Buy

―

Reiterated

08/11/25

DZ BANK AG Remains a Buy on Bayer (0P6S)

James Quigley

Goldman Sachs

€34→€35

Buy

23.15%

Upside

Reiterated

08/07/25

Goldman Sachs Sticks to Their Buy Rating for Bayer (0P6S)

Christian Faitz

Kepler Capital

€33

Buy

16.12%

Upside

Reiterated

08/06/25

Kepler Capital Sticks to Their Buy Rating for Bayer (0P6S)

Richard Vosser

J.P. Morgan

€25

Hold

-12.03%

Downside

Reiterated

08/06/25

Bayer (0P6S) Gets a Hold from J.P. Morgan

Falko Friedrichs

Deutsche Bank

€23

Hold

-19.07%

Downside

Reiterated

08/04/25

Florent Cespedes

Bernstein

€30

Hold

5.56%

Upside

Reiterated

08/01/25

Bernstein Keeps Their Hold Rating on Bayer (0P6S)

Vincent Andrews

Morgan Stanley

€28

Hold

-1.48%

Downside

Reiterated

06/27/25

Morgan Stanley Remains a Hold on Bayer (0P6S)

Emily Field

Barclays

€25

Hold

-12.03%

Downside

Reiterated

06/27/25

Barclays Sticks to Its Hold Rating for Bayer (0P6S)

Rajesh Kumar

HSBC

€20→€32

Buy

12.60%

Upside

Upgraded

06/11/25

Bayer upgraded to Buy from Hold at HSBCBayer upgraded to Buy from Hold at HSBC

Sachin Jain

Bank of America Securities

€27→€30

Buy

5.56%

Upside

Upgraded

05/02/25

BofA Securities Upgrades Bayer AG (BAYN:GR) (BAYRY) to BuyBofA Securities analyst Sachin Jain upgraded Bayer AG (BAYN:GR) (OTC: BAYRY) from Neutral to Buy with a price target of EUR30.00 (from EUR27.00).

Andreas Heine

Stifel Nicolaus

€28

Hold

-1.48%

Downside

Reiterated

03/05/25

Bayer's Financial Challenges and Mixed Divisional Performance Lead to Hold Rating

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Veda Pharmyne

TR | OpenAI - 4o

€28→€29

Hold

2.04%

Upside

Reiterated

08/20/25

AI Generated ArticleAI Generated Article

Chris Counihan

Jefferies

€25

Hold

-12.03%

Downside

Reiterated

08/18/25

Jefferies Sticks to Their Hold Rating for Bayer (0P6S)

Matthew Weston

UBS

€24→€26

Hold

-8.52%

Downside

Reiterated

08/14/25

Sebastian Bray

Berenberg Bank

€26

Hold

-8.52%

Downside

Reiterated

08/12/25

Bayer (0P6S) Receives a Hold from Berenberg Bank

Peter Spengler

DZ BANK AG

―

Buy

―

Reiterated

08/11/25

DZ BANK AG Remains a Buy on Bayer (0P6S)

James Quigley

Goldman Sachs

€34→€35

Buy

23.15%

Upside

Reiterated

08/07/25

Goldman Sachs Sticks to Their Buy Rating for Bayer (0P6S)

Christian Faitz

Kepler Capital

€33

Buy

16.12%

Upside

Reiterated

08/06/25

Kepler Capital Sticks to Their Buy Rating for Bayer (0P6S)

Richard Vosser

J.P. Morgan

€25

Hold

-12.03%

Downside

Reiterated

08/06/25

Bayer (0P6S) Gets a Hold from J.P. Morgan

Falko Friedrichs

Deutsche Bank

€23

Hold

-19.07%

Downside

Reiterated

08/04/25

Florent Cespedes

Bernstein

€30

Hold

5.56%

Upside

Reiterated

08/01/25

Bernstein Keeps Their Hold Rating on Bayer (0P6S)

Vincent Andrews

Morgan Stanley

€28

Hold

-1.48%

Downside

Reiterated

06/27/25

Morgan Stanley Remains a Hold on Bayer (0P6S)

Emily Field

Barclays

€25

Hold

-12.03%

Downside

Reiterated

06/27/25

Barclays Sticks to Its Hold Rating for Bayer (0P6S)

Rajesh Kumar

HSBC

€20→€32

Buy

12.60%

Upside

Upgraded

06/11/25

Bayer upgraded to Buy from Hold at HSBCBayer upgraded to Buy from Hold at HSBC

Sachin Jain

Bank of America Securities

€27→€30

Buy

5.56%

Upside

Upgraded

05/02/25

Andreas Heine

Stifel Nicolaus

€28

Hold

-1.48%

Downside

Reiterated

03/05/25

Bayer's Financial Challenges and Mixed Divisional Performance Lead to Hold Rating

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bayer

1 Month

xxx

Success Rate

12/20 ratings generated profit

Average Return

+1.14%

reiterated a xxx

rating 22 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +1.14% per trade.

3 Months

xxx

Success Rate

14/20 ratings generated profit

Average Return

+2.32%

reiterated a xxx

rating 22 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +2.32% per trade.

1 Year

James QuigleyGoldman Sachs

Success Rate

14/20 ratings generated profit

Average Return

+5.00%

reiterated a buy rating 22 days ago

Copying James Quigley's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +5.00% per trade.

2 Years

xxx

Success Rate

14/20 ratings generated profit

Average Return

+2.42%

reiterated a xxx

rating 22 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 70.00% of your transactions generating a profit, with an average return of +2.42% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BAYN Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BAYN has received 10 Buy Ratings, 31 Hold Ratings, and 0 Sell Ratings. BAYN average Analyst price target in the past 3 months is 28.08.

Each month's total comprises the sum of three months' worth of ratings.

BAYN Financial Forecast

BAYN Earnings Forecast

Next quarter’s earnings estimate for BAYN is €0.38 with a range of €0.26 to €0.59. The previous quarter’s EPS was €1.23. BAYN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year BAYN has Outperformed its overall industry.

BAYN Sales Forecast

Next quarter’s sales forecast for BAYN is €9.76B with a range of €9.59B to €10.02B. The previous quarter’s sales results were €10.74B. BAYN beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.91% of the time in the same period. In the last calendar year BAYN has Outperformed its overall industry.

BAYN Stock Forecast FAQ

What is DE:BAYN’s average 12-month price target, according to analysts?

Based on analyst ratings, Bayer’s 12-month average price target is 28.08.

What is DE:BAYN’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for DE:BAYN, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Bayer a Buy, Sell or Hold?

Bayer has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 9 hold ratings and 0 sell ratings.

What is Bayer’s share price target?

The average share price target for Bayer is 28.08. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €35.00 ,and the lowest forecast is €23.00. The average share price target represents -1.20% Decrease from the current price of €28.42.

What do analysts say about Bayer?

Bayer’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Bayer?

To buy shares of DE:BAYN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Bayer (BAYN) Stock Forecast & Price Target

BAYN Analyst Ratings

BAYN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Bayer

BAYN Analyst Recommendation Trends

BAYN Financial Forecast

BAYN Earnings Forecast

BAYN Sales Forecast

BAYN Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts